These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Pharmacogenetics of depression in elderly patients]. Monnin J; Haffen E; Sechter D; Vandel P Psychol Neuropsychiatr Vieil; 2009 Mar; 7(1):43-55. PubMed ID: 19251571 [TBL] [Abstract][Full Text] [Related]
23. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Schosser A; Kasper S Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481 [TBL] [Abstract][Full Text] [Related]
24. Some antidepressants interfere with tamoxifen more than others. Harv Womens Health Watch; 2010 Mar; 17(7):6. PubMed ID: 20480970 [No Abstract] [Full Text] [Related]
26. Pharmacokinetic aspects of antidepressant treatment in the elderly. Norman TR Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):329-44. PubMed ID: 8475316 [TBL] [Abstract][Full Text] [Related]
27. Psychopharmacologic treatment of depression in the medically ill. Beliles K; Stoudemire A Psychosomatics; 1998; 39(3):S2-19. PubMed ID: 9664784 [TBL] [Abstract][Full Text] [Related]
28. Antidepressant drugs in the elderly--role of the cytochrome P450 2D6. Vandel P World J Biol Psychiatry; 2003 Apr; 4(2):74-80. PubMed ID: 12692778 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic considerations of antidepressant use in the elderly. DeVane CL; Pollock BG J Clin Psychiatry; 1999; 60 Suppl 20():38-44. PubMed ID: 10513858 [TBL] [Abstract][Full Text] [Related]
30. Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression. Scates AC; Doraiswamy PM Ann Pharmacother; 2000 Nov; 34(11):1302-12. PubMed ID: 11098346 [TBL] [Abstract][Full Text] [Related]
31. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants]. Jeleń A; Sałagacka A; Balcerczak E Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991 [TBL] [Abstract][Full Text] [Related]
32. Sex differences in pharmacokinetics of antidepressants. Kokras N; Dalla C; Papadopoulou-Daifoti Z Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):213-26. PubMed ID: 21192772 [TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of psychotropic drug response. Malhotra AK; Murphy GM; Kennedy JL Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641 [TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomic strategy for individualizing antidepressant therapy. Lin KM; Perlis RH; Wan YJ Dialogues Clin Neurosci; 2008; 10(4):401-8. PubMed ID: 19170397 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics in depression and antidepressants. Bondy B Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381 [TBL] [Abstract][Full Text] [Related]
36. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Yonkers KA; Kando JC; Cole JO; Blumenthal S Am J Psychiatry; 1992 May; 149(5):587-95. PubMed ID: 1575248 [TBL] [Abstract][Full Text] [Related]